CATX Robert F Williamson III buys $50K worth of shares
Apr 02, 2025, 4:33 AM
0.00%
What does CATX do
Perspective Therapeutics, based in Seattle, is a biotechnology company focused on developing radiopharmaceuticals for cancer treatment using the alpha-emitting isotope 212Pb. Their programs for melanoma and neuroendocrine tumors are in Phase I/IIa trials.
Robert F Williamson III bought 22,192 shares of CATX on 28 March at $2.27 per share, worth a total of $50K. They now own 70,837 CATX shares, or a 46% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
